相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer
Jose M. Mates et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Autophagy and mitophagy in cancer metabolic remodelling
Fabio Ferro et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein
Xi Shen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Pro- and antitumor effects of mitochondrial reactive oxygen species
Valery L. Payen et al.
CANCER AND METASTASIS REVIEWS (2019)
Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas
Hao-Wen Sim et al.
CLINICAL CANCER RESEARCH (2019)
Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
Bozena Kaminska et al.
MOLECULES (2019)
Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 Signaling
Jae Woo Jung et al.
CELL METABOLISM (2019)
PGC-1α Controls Mitochondrial Biogenesis in Drug-Resistant Colorectal Cancer Cells by Regulating Endoplasmic Reticulum Stress
Chul Won Yun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The landscape of cancer cell line metabolism
Haoxin Li et al.
NATURE MEDICINE (2019)
The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
Pouya Saraei et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Mitochondrial DNA: Distribution, Mutations, and Elimination
Chaojun Yan et al.
CELLS (2019)
YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway
Yaqun Ye et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
Small Regulatory Molecules Acting Big Cancer: Potential Role of Mito-miRs in Cancer
Praveen Sharma et al.
CURRENT MOLECULAR MEDICINE (2019)
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Ali S. Alzahrani
SEMINARS IN CANCER BIOLOGY (2019)
Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer
Guan Li et al.
ONCOLOGY LETTERS (2019)
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival
Georgios Batsios et al.
SCIENTIFIC REPORTS (2019)
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Fabiana Crispo et al.
CELLS (2019)
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL
Toby A. Eyre et al.
HEMATOLOGICAL ONCOLOGY (2019)
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment
Dennis Heinzen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers A meta-analysis
Haidong Ye et al.
MEDICINE (2019)
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms
Edward Wolin et al.
PLOS ONE (2019)
Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments
Shengchen Lin et al.
CELL REPORTS (2019)
Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis
Sarah M. Wade et al.
EBIOMEDICINE (2019)
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Frank Weinberg et al.
CANCERS (2019)
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
Joseph J. Caumanns et al.
CANCER LETTERS (2019)
Mitochondrial supercomplex assembly promotes breast and endometrial tumorigenesis by metabolic alterations and enhanced hypoxia tolerance
Kazuhiro Ikeda et al.
NATURE COMMUNICATIONS (2019)
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma
Charlotte M. Huijts et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Hyperpolarized MRI Visualizes Warburg Effects and Predicts Treatment Response to mTOR Inhibitors in Patient-Derived ccRCC Xenograft Models
Yiyu Dong et al.
CANCER RESEARCH (2019)
Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription
Song Fan et al.
CANCER RESEARCH (2019)
The oncometabolite d-2-hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway
Jiyoon Seok et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Rapamycin enhances growth inhibition on urothelial carcinoma cells through LKB1 deficiency-mediated mitochondrial dysregulation
Young Mi Whang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma
Keisuke Miyake et al.
MEDICAL ONCOLOGY (2019)
mTOR as a central hub of nutrient signalling and cell growth
Joungmok Kim et al.
NATURE CELL BIOLOGY (2019)
Targeting Metabolic-Redox Circuits for Cancer Therapy
Kui Wang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review
Thomas Weichhart
GERONTOLOGY (2018)
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Prakash Chinnaiyan et al.
NEURO-ONCOLOGY (2018)
Role of mitochondrial function in the invasiveness of human colon cancer cells
Chen-Sung Lin et al.
ONCOLOGY REPORTS (2018)
Oncogene-Driven Metabolic Alterations in Cancer
Hye-Young Min et al.
BIOMOLECULES & THERAPEUTICS (2018)
AMPK: Sensing Glucose as well as Cellular Energy Status
Sheng-Cai Lin et al.
CELL METABOLISM (2018)
S6 kinase 1 plays a key role in mitochondrial morphology and cellular energy flow
Quangdon Tran et al.
CELLULAR SIGNALLING (2018)
Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
Tamar Safra et al.
CLINICAL BREAST CANCER (2018)
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
Andreas Wicki et al.
EUROPEAN JOURNAL OF CANCER (2018)
TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β
Barbara Ogorek et al.
HUMAN MOLECULAR GENETICS (2018)
In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis
Ildiko Krencz et al.
HUMAN PATHOLOGY (2018)
miR-125a induces apoptosis, metabolism disorder and migration impairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission
Lichao Pan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes
Peipei Lin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results
Jacques Dantal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Mitochondrial fission promotes cell migration by Ca2+/CaMKII/ERK/FAK pathway in hepatocellular carcinoma
Xiacheng Sun et al.
LIVER INTERNATIONAL (2018)
Mitochondria in health and disease
Sanjiban Chakrabarty et al.
MITOCHONDRION (2018)
The multifaceted contributions of mitochondria to cellular metabolism
Jessica B. Spinelli et al.
NATURE CELL BIOLOGY (2018)
Additive cytotoxic effects of radiation and mTOR inhibitors in a cervical cancer cell line
Daniele Xavier Assad et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
Grace R. Anderson et al.
NATURE COMMUNICATIONS (2018)
Streptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines
Vipin Mohan Dan et al.
SCIENTIFIC REPORTS (2018)
Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC)
Yu Zhang et al.
MEDICAL SCIENCE MONITOR (2018)
Everolimus-based combination therapies for HR+, HER2-metastatic breast cancer
Joyce O'Shaughnessy et al.
CANCER TREATMENT REVIEWS (2018)
Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study
Nobuaki Matsubara et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Targeting mitochondria in cancer: current concepts and immunotherapy approaches
Sergey Pustylnikov et al.
TRANSLATIONAL RESEARCH (2018)
mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma
Luca Drusian et al.
CELL REPORTS (2018)
Metabolic reprogramming of mitochondrial respiration in metastatic cancer
P. M. Herst et al.
CANCER AND METASTASIS REVIEWS (2018)
Role of HIF-1 in Cancer Progression: Novel Insights. A Review
Aldo Pezzuto et al.
CURRENT MOLECULAR MEDICINE (2018)
Pathways to balance mitochondrial translation and protein import
Chantal Priesnitz et al.
GENES & DEVELOPMENT (2018)
Dynamin-related protein 1 has membrane constricting and severing abilities sufficient for mitochondrial and peroxisomal fission
Sukrut C. Kamerkar et al.
NATURE COMMUNICATIONS (2018)
被撤回的出版物: Reduced miR-125a-5p level in non-small-cell lung cancer is associated with tumour progression (Publication with Expression of Concern. See vol. 10, 2020) (Retracted article. See vol. 10, 2020)
Hongxu Liu et al.
OPEN BIOLOGY (2018)
Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States
Tasleem Arif et al.
CANCERS (2018)
mTOR signalling and cellular metabolism are mutual determinants in cancer
Dirk Mossmann et al.
NATURE REVIEWS CANCER (2018)
Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours
Kathleen N. Moore et al.
ESMO OPEN (2018)
Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
Zhengqiu Zhou et al.
ANTIOXIDANTS (2018)
Interplay of mitochondrial metabolism and microRNAs
Julian Geiger et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Cell Biology of the Mitochondrion
Alexander M. van der Bliek et al.
GENETICS (2017)
The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required
Kai Zhao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
Zoltan Hujber et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
RICTOR expression in esophageal squamous cell carcinoma and its clinical significance
Wei-Jia Jiang et al.
MEDICAL ONCOLOGY (2017)
mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1
Masahiro Morita et al.
MOLECULAR CELL (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Twenty-five years of mTOR: Uncovering the link from nutrients to growth
David M. Sabatini
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Metformin synergizes with rapamycin to inhibit the growth of pancreatic cancer in�vitro and in�vivo
Jia‑Wei Zhang et al.
Oncology Letters (2017)
mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation
Victor H. Villar et al.
NATURE COMMUNICATIONS (2017)
Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells
Emmanuel Dornier et al.
NATURE COMMUNICATIONS (2017)
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Davinder Singh et al.
CELL AND BIOSCIENCE (2017)
Cell Biology of the Mitochondrion
Alexander M. van der Bliek et al.
GENETICS (2017)
Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory
Rebecca R. J. Collins et al.
CLINICAL CHEMISTRY (2017)
Phosphorylated mTOR Expression Profiles in Human Normal and Carcinoma Tissues
Hojung Lee
DISEASE MARKERS (2017)
Mitochondrial dynamics as regulators of cancer biology
Andrew Paul Trotta et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Exposure to high levels of fumarate and succinate leads to apoptotic cytotoxicity and altered global DNA methylation profiles in vitro
Johannes F. Wentzel et al.
BIOCHIMIE (2017)
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
Gerke Ariaans et al.
BMC CANCER (2017)
mTOR Signaling in Growth, Metabolism, and Disease (vol 168, pg 960, 2017)
Robert A. Saxton et al.
CELL (2017)
Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma
Xulu Ye et al.
ANTICANCER RESEARCH (2016)
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Yangzom D. Bhutia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer
D. de Wit et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Lynne Chantranupong et al.
CELL (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs
Valentina Gandin et al.
GENOME RESEARCH (2016)
Cooperative and independent roles of the Drp1 adaptors Mff, MiD49 and MiD51 in mitochondrial fission
Laura D. Osellame et al.
JOURNAL OF CELL SCIENCE (2016)
Mitochondrial Dynamics and Metabolic Regulation
Timothy Wai et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
Melissa Carbonneau et al.
NATURE COMMUNICATIONS (2016)
Impaired Mitochondrial Dynamics and Mitophagy in Neuronal Models of Tuberous Sclerosis Complex
Darius Ebrahimi-Fakhari et al.
CELL REPORTS (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
A Phase I Dose-Escalation Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the Dual mTORC1/mTORC2 Kinase Inhibitor CC-223 in Patients With Advanced Solid Tumors or Multiple Myeloma
Johanna C. Bendell et al.
CANCER (2015)
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling
Xudong Fu et al.
CELL METABOLISM (2015)
Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9
Jennifer Jung et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
An mTORC1-Mdm2-Drosha Axis for miRNA Biogenesis in Response to Glucose- and Amino Acid-Deprivation
Peiying Ye et al.
MOLECULAR CELL (2015)
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Manuele Rebsamen et al.
NATURE (2015)
Targeting the translation machinery in cancer
Mamatha Bhat et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A giant molecular proton pump: structure and mechanism of respiratory complex I
Leonid A. Sazanov
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Shuyu Wang et al.
SCIENCE (2015)
Differential regulation of mTORC1 by leucine and glutamine
Jenna L. Jewell et al.
SCIENCE (2015)
Regulation of mTORC1 by PI3K signaling
Christian C. Dibble et al.
TRENDS IN CELL BIOLOGY (2015)
mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3
K. M. Dodd et al.
ONCOGENE (2015)
Tumor Cells Switch to Mitochondrial Oxidative Phosphorylation under Radiation via mTOR-Mediated Hexokinase II Inhibition - A Warburg-Reversing Effect
Chung-Ling Lu et al.
PLOS ONE (2015)
mTOR-targeted therapy: Differential perturbation to mitochondrial membrane potential and permeability transition pore plays a role in therapeutic response
Jae Eun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer
Margreet C. M. Vissers et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
MicroRNAs as regulators of mitochondrial function: Role in cancer suppression
Marco Tomasetti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
Nader Husseinzadeh et al.
GYNECOLOGIC ONCOLOGY (2014)
The Oncometabolite Fumarate Promotes Pseudohypoxia Through Noncanonical Activation of NF-κB Signaling
Karthigayan Shanmugasundaram et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hexokinase-II Positively Regulates Glucose Starvation-Induced Autophagy through TORC1 Inhibition
David J. Roberts et al.
MOLECULAR CELL (2014)
The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR
Randall M. Chin et al.
NATURE (2014)
Mitochondrial form and function
Jonathan R. Friedman et al.
NATURE (2014)
PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
Valerie S. LeBleu et al.
NATURE CELL BIOLOGY (2014)
The Sestrins Interact with GATOR2 to Negatively Regulate the Amino-Acid-Sensing Pathway Upstream of mTORC1
Lynne Chantranupong et al.
CELL REPORTS (2014)
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential
Helene Pelicano et al.
BREAST CANCER RESEARCH (2014)
Transcription Factor YY1 Contributes to Tumor Growth by Stabilizing Hypoxia Factor HIF-1α in a p53-Independent Manner
Shourong Wu et al.
CANCER RESEARCH (2013)
The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
Alfred Csibi et al.
CELL (2013)
mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation
Masahiro Morita et al.
CELL METABOLISM (2013)
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
A. V. Tinker et al.
GYNECOLOGIC ONCOLOGY (2013)
Reprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin
Hana Totary-Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Fis1 acts as a mitochondrial recruitment factor for TBC1D15 that is involved in regulation of mitochondrial morphology
Kenta Onoue et al.
JOURNAL OF CELL SCIENCE (2013)
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Antonio F. Santidrian et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
HIF-independent role of prolyl hydroxylases in the cellular response to amino acids
R. V. Duran et al.
ONCOGENE (2013)
Apoptosis induced by PGC-1β in breast cancer cells is mediated by the mTOR pathway
Libin Wang et al.
ONCOLOGY REPORTS (2013)
The mTOR pathway negatively controls ATM by up-regulating miRNAs
Changxian Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mitochondrial autophagy in cells with mtDNA mutations results from synergistic loss of transmembrane potential and mTORC1 inhibition
Robert W. Gilkerson et al.
HUMAN MOLECULAR GENETICS (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Yin Yang-1 inhibits tumor cell growth and inhibits p21WAF1/Cip1 complex formation with cdk4 and cyclin D1
Hideto Ishii et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Defective Mitochondrial Morphology and Bioenergetic Function in Mice Lacking the Transcription Factor Yin Yang 1 in Skeletal Muscle
Sharon M. Blaettler et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Glutaminolysis Activates Rag-mTORC1 Signaling
Raul V. Duran et al.
MOLECULAR CELL (2012)
TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
Christian C. Dibble et al.
MOLECULAR CELL (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
PTEN/Akt Signaling Controls Mitochondrial Respiratory Capacity through 4E-BP1
Chong Kiat Goo et al.
PLOS ONE (2012)
Distinct perturbation of the translatome by the antidiabetic drug metformin
Ola Larsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ Visualizing the therapeutic effects of metformin in tumor tissue
Diana Whitaker-Menezes et al.
CELL CYCLE (2011)
MiD49 and MiD51, new components of the mitochondrial fission machinery
Catherine S. Palmer et al.
EMBO REPORTS (2011)
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2011)
During autophagy mitochondria elongate, are spared from degradation and sustain cell viability
Ligia C. Gomes et al.
NATURE CELL BIOLOGY (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation
Angelika S. Rambold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Updates of mTOR Inhibitors
Hongyu Zhou et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly
Takeshi Kaizuka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells
Hidenori Otera et al.
JOURNAL OF CELL BIOLOGY (2010)
Glucose Addiction of TSC Null Cells Is Caused by Failed mTORC1-Dependent Balancing of Metabolic Demand with Supply
Andrew Y. Choo et al.
MOLECULAR CELL (2010)
Physical Association of PDK1 with AKT1 Is Sufficient for Pathway Activation Independent of Membrane Localization and Phosphatidylinositol 3 Kinase
Zhiyong Ding et al.
PLOS ONE (2010)
mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
Ryan J. O. Dowling et al.
SCIENCE (2010)
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Paul Nicklin et al.
CELL (2009)
Autophagy Suppresses Tumorigenesis through Elimination of p62
Robin Mathew et al.
CELL (2009)
Glutamine homeostasis and mitochondrial dynamics
Jose M. Mates et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts
Daniela Gaglio et al.
PLOS ONE (2009)
Direct control of mitochondrial function by mTOR
Arvind Ramanathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Coordination of mitochondrial bioenergetics with G1 phase cell cycle progression
Stefan M. Schieke et al.
CELL CYCLE (2008)
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
Tsuneo Ikenoue et al.
EMBO JOURNAL (2008)
Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
Alfredo Toschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy
Leri S. Faried et al.
MOLECULAR CARCINOGENESIS (2008)
Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver disease
Scott J. Cotler et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex
John T. Cunningham et al.
NATURE (2007)
Identification of Protor as a novel Rictor-binding component of mTOR complex-2
Laura R. Pearce et al.
BIOCHEMICAL JOURNAL (2007)
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Sibylle Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding
Lifu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity
Qian Yang et al.
GENES & DEVELOPMENT (2006)
MTOR, translation initiation and cancer
Y. Mamane et al.
ONCOGENE (2006)
The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity
Stefan M. Schieke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Current development of mTOR inhibitors as anticancer agents
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein
Kwang-Jin Oh et al.
JOURNAL OF VIROLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells
D Tondera et al.
JOURNAL OF CELL SCIENCE (2005)
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation
I Beuvink et al.
CELL (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion
Y Eura et al.
JOURNAL OF BIOCHEMISTRY (2003)
A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets
AM Arsham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells
A Santel et al.
JOURNAL OF CELL SCIENCE (2003)
TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function
SS Schaim et al.
CURRENT BIOLOGY (2003)
The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif
H Nojima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α):: Transcriptional coactivator and metabolic regulator
P Puigserver et al.
ENDOCRINE REVIEWS (2003)
Construction of a protein-detection system using a loop peptide library with a fluorescence label
M Takahashi et al.
CHEMISTRY & BIOLOGY (2003)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
Nuclear activators and coactivators in mammalian mitochondrial biogenesis
RC Scarpulla
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction
BN Desai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor
JD Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy
C Delettre et al.
NATURE GENETICS (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
